Hi, I am inquiring regarding Methergen use guidelines. I am working as an RN, IBCLC on a maternity floor in the Sountheast. Recently my hospital and Corporate have been enforcing protocol that does not allow mothers who were given Methergen to breastfeed for 12 hours. I am hoping that you can provide guidance/research regarding Methergen amounts passed through breastmilk from mother to baby.This is obviously not ideal as we are hoping to assist in breastfeeding as soon as possible after birth.This will result in an increase in formula use due to the inability to breastfeed for such time periods.Please let me know if you need additional information.
Announcement
Collapse
No announcement yet.
Welcome to our forum! Before posting your questions, please read the following terms:
- 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
- 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
- 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
- 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.
By posting to the forums, you acknowledge and agree to these terms.
The InfantRisk team
Methergine
Collapse
X
-
Noreen Webb,
Methergine is rated an L2-limited data-probably compatible. The amount that transfers into breast milk is only 0.72-5.46% of the mothers dose. We believe with this low transfer rate it is safe for mothers to nurse especially in the colostrum phase when the infant is getting such a low volume of milk. Product labeling in the US recommends waiting 12 hours to nurse after the last dose of Methergine most likely based on unpublished adverse effects in breastfed infants when the mothers were treated with Methergine for several days. Short term use especially in the colostrum phase is not expected to transfer clinically relevant amounts to the breastfed infant or cause any adverse effects. We still recommend monitoring the infant for vomiting, diarrhea, agitation and tachycardia. Prolonged use may also suppress the mothers milk production.
Sandra Lovato R.N.
InfantRisk Center
Comment